Stock Market - Most Anticipated Earnings Releases for the week beginning April 30th, 2018 |
- Most Anticipated Earnings Releases for the week beginning April 30th, 2018
- Is the app “value investing 2.0” worth using? Havnt been able to find info about it outside the comments in the App Store
- How much do the futures actually tell us about the future of the market?
- iQiyi earnings up 57%
- Here's the key difference between Amazon and Alphabet right now
- Opions on KMPH (KemPharm) stock?
Most Anticipated Earnings Releases for the week beginning April 30th, 2018 Posted: 28 Apr 2018 04:12 AM PDT
| ||
Posted: 28 Apr 2018 03:59 PM PDT | ||
How much do the futures actually tell us about the future of the market? Posted: 28 Apr 2018 03:21 PM PDT Are the future contracts tradings really a good indicator of what to expect when the market opens the next day? [link] [comments] | ||
Posted: 28 Apr 2018 02:16 PM PDT For those who don't mind a bit of China risk iQiyi (IQ), China's most popular video platform, reported remarkable growth with revenue up 57% at $777 million for the first quarter with strong growth across the board. Guidance for Q2 was for revenues to hit a record range between $924 million to $963.1 million. The company also announced a partnership with Chinese online retail juggernaut JD.com to link membership programs, allowing paying users of one platform's membership program to enjoy the perks of the other's premium features. With rapid growth and the stock valued at just over 3 times Q2 annualised revenues it looks very cheap. This post is not a recommendation to buy or sell any security or derivative. Stocks are not suitable for all investors. Please do your own research. [link] [comments] | ||
Here's the key difference between Amazon and Alphabet right now Posted: 28 Apr 2018 01:57 PM PDT
https://www.cnbc.com/2018/04/27/analyst-on-alphabet-vs-amazon-long-term-growth-margins.html [link] [comments] | ||
Opions on KMPH (KemPharm) stock? Posted: 27 Apr 2018 11:09 PM PDT The guy running the show at KemPharm is a well-known chemist who used to be the head of Shire. His specialty is prodrugs and he has an incredibly successful one under his belt: He was the inventor of Vyvanse. His new company has a Hydrocodone product called Adapaz. As opioid regulations tighten, it seems like an abuse-resistant product will increase in demand. Thoughts? [link] [comments] |
You are subscribed to email updates from r/StockMarket - Reddit's front page of the stock market, financial news. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
No comments:
Post a Comment